leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 18:34:18 - browse：1581

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

knowledge

WSS

Trump used to be more articulate. What could explain the change?

Doctors are clamoring for more clarity on Paxlovid prescribing

St. Louis police protesters begin picking up checks in $4.9 million settlement

Biogen Alzheimer’s drug launch off to slow start

BioAge raises $170M for combination therapy with Zepbound

Slovenia has suffered its worst

focus

leisure time

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Slovenia has suffered its worst

As demand for Covid shots wanes, Moderna seeks its next success

The Readout: Gilead, Bernie Sanders, and other pharma news

The cancer drug shortage isn’t new — and neither are the solutions

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Vaccine advisory panel ACIP left half staffed by HHS

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

To avoid data mishandling cases, universities eye AI and other tools

entertainment

Key House Republican on health care plans exit from Congress

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Readout LOUD podcast: How biotech is using artificial intelligence

The Readout: Gilead, Bernie Sanders, and other pharma news

Biogen Alzheimer’s drug launch off to slow start

focus

knowledge

knowledge

leisure time